Can lab-grown leather production be scaled up to meet massive materials demand of industry?

Right now a company is generating 10 by 10cm squared tissues, just over 1mm thick. Can it scale up? Credit: Ivan Radic via CC-BY-2.0
Right now a company is generating 10 by 10cm squared tissues, just over 1mm thick. Can it scale up? Credit: Ivan Radic via CC-BY-2.0

Tyneside biotech business 3D Bio-Tissues say we are just a few years away from lab-grown leather goods after creating animal ‘skin’ without the need for animals.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Dr Che Connon, chief executive said: “It works in the same way that leather works, it’s made from the same thing – skin. The animal cells are used at the very beginning and a media to grow those cells. There’s a couple of tricks we’ve been developing over the years. One is to direct those cells, give them some direction they respond to and they arrange themselves in a skin-like way and importantly, make all the skin-like molecules. Once they’ve arranged themselves the result is skin.

Mr Connon said it would take around five years to scale up the technology before we see large, leather products come to the market, but it is already in talks with companies keen to make ethical goods from its pioneering technology.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
RFKjr-Tech-Vax-Misinfo
As U.S. officials spread medical misinformation, scientists fact check online
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.